This man brings Synbiotic into the advisory board

In its preparations for cannabis legalization, the start-up is receiving prominent support from a cannabis multi-entrepreneur.

Synbiotic has appointed cannabis entrepreneur Bruce Linton as chairman of its newly created advisory board. The listed company wants to benefit from his industry knowledge in the upcoming cannabis legalization.

Linton is a well-known figure in the global cannabis scene: he is the founder and former Chairman and CEO of Canopy Growth Corporation. At the time of his departure, the cannabis company was said to be worth around 20 billion Canadian dollars and supplied more than 25 percent of the Canadian market with cannabis. He also founded several other global cannabis companies listed on various exchanges including NYSE, Nasdaq, TSX, TSX:V, CSE and ASX.

"I see tremendous potential in the European market, especially with the recent announcement of legalization in Germany," says Bruce Linton. "I believe Synbiotic SE is well positioned to take full advantage of legalization and become the dominant cannabis company in Europe." Linton was also one of the investors in the latest financing round and now holds around five percent of Synbiotic's shares. He is remunerated for his work as an advisory board member depending on the development of the share price.